Robeco Institutional Asset Management B.V.
Position in JNJ — Johnson & Johnson
CIK 1418773
ROTTERDAM, P7
Position in JNJ
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$420,742,105
+$93,562,020 QoQ
Shares Held
1,721,249
+8.9% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 53.8159208807093.ToString("F0")%
Shared 0.ToString("F0")%
None 46.1840791192907.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Robeco Institutional Asset Management B.V. holds $3,535,801,813 across 9 Drug Manufacturers - General names. JNJ ranks #4 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
3,250,326 | $706,913,401 | |
| 2 | LLY |
ELI LILLY & Co
|
653,146 | $600,744,096 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
3,354,394 | $467,501,891 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
1,721,249 | $420,742,105 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
6,733,740 | $408,401,331 | |
| 6 | PFE |
Pfizer Inc
|
11,138,434 | $312,767,226 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,322,293 | $279,348,624 | |
| 8 | AMGN |
Amgen Inc
|
566,919 | $199,470,450 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $420,742,105 | 1,721,249 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $327,180,085 | 1,580,962 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $329,951,552 | 1,779,482 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $275,745,369 | 1,805,207 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $295,199,180 | 1,780,024 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $235,905,011 | 1,631,206 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $225,422,867 | 1,390,984 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $198,085,824 | 1,355,267 | Shares | Defined | 2024-07-23 | |
| 2024-03-31 | $211,324,597 | 1,335,891 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $186,973,578 | 1,192,890 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $190,802,783 | 1,225,058 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $250,065,629 | 1,510,788 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $242,538,420 | 1,564,764 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $262,410,042 | 1,485,480 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $264,583,083 | 1,619,632 | Shares | Defined | 2022-12-01 | |
| 2022-06-30 | $308,281,261 | 1,736,698 | Shares | Defined | 2022-12-01 | |
| 2022-03-31 | $327,239,244 | 1,846,410 | Shares | Defined | 2022-12-01 | |
| 2021-12-31 | $334,959,678 | 1,958,027 | Shares | Defined | 2022-12-01 | |
| 2021-09-30 | $388,222,582 | 2,403,855 | Shares | Defined | 2022-12-01 | |
| 2021-06-30 | $396,778,431 | 2,408,513 | Shares | Defined | 2022-12-01 | |
| 2021-03-31 | $437,405,691 | 2,661,428 | Shares | Defined | 2022-12-01 | |
| 2020-12-31 | $408,104,438 | 2,593,115 | Shares | Defined | 2022-12-01 | |
| 2020-09-30 | $336,679,316 | 2,261,414 | Shares | Defined | 2021-01-19 | |
| 2020-06-30 | $295,491,474 | 2,101,198 | Shares | Defined | 2021-01-19 | |
| 2020-03-31 | $249,711,514 | 1,904,305 | Shares | Defined | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||